Arrowhead Research | ARWR - DEBITO





DEBITO Cambiamento Data
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 312.77M 53.52M 2025-12
Heron Therapeutics USD 149.65M 157K 2024-09
Incyte USD 39.43M 982K 2026-03
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Ligand Pharmaceuticals USD 451.49M 494K 2025-12
Merck USD 49.34B 7.97B 2025-12
Moderna USD 1.31B 571M 2025-12
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 47B 11.62B 2026-03
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
TG Therapeutics USD 253.71M 8.37M 2025-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 1.99B 44M 2026-03
Xencor USD 187.75M 118.48M 2025-12